115 related articles for article (PubMed ID: 2917596)
1. 5-Methoxypsoralen increases evening sleepiness in humans: possible involvement of the melatonin secretion.
Souêtre E; Salvati E; Belugou JL; Krebs B; Darcourt G
Eur J Clin Pharmacol; 1989; 36(1):91-2. PubMed ID: 2917596
[TBL] [Abstract][Full Text] [Related]
2. 5-Methoxypsoralen increases the plasma melatonin levels in humans.
Souetre E; Salvati E; Belugou JL; de Galeani B; Krebs B; Ortonne JP; Darcourt G
J Invest Dermatol; 1987 Aug; 89(2):152-5. PubMed ID: 3598208
[TBL] [Abstract][Full Text] [Related]
3. 5-Methoxypsoralen inhibits 6-hydroxylation of melatonin in the rat.
Mauviard F; Raynaud F; Geoffriau M; Claustrat B; Pévet P
Biol Signals; 1995; 4(1):32-41. PubMed ID: 7550582
[TBL] [Abstract][Full Text] [Related]
4. 5-Methoxypsoralen increases the sensitivity of the retina to light in humans.
Souêtre E; De Galeani B; Gastaud P; Salvati E; Darcourt G
Eur J Clin Pharmacol; 1989; 36(1):59-61. PubMed ID: 2917589
[TBL] [Abstract][Full Text] [Related]
5. 5-Methoxypsoralen: effect on the noradrenaline circadian rhythm of sleep-deprived subjects.
Candito M; Pringuey D; Lehert P; Drici M; Souêtre E; Chambon P; Darcourt G
Life Sci; 1993; 53(22):PL355-8. PubMed ID: 8231642
[TBL] [Abstract][Full Text] [Related]
6. 5-Methoxypsoralen enhances plasma melatonin concentrations in the male rat: non-noradrenergic-mediated stimulation and lack of effect in pinealectomized animals.
Mauviard F; Pévet P; Forlot P
J Pineal Res; 1991 Aug; 11(1):35-41. PubMed ID: 1941505
[TBL] [Abstract][Full Text] [Related]
7. 8-methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism.
Garde E; Micic S; Knudsen K; Angelo HR; Wulf HC
Photochem Photobiol; 1994 Nov; 60(5):475-80. PubMed ID: 7800718
[TBL] [Abstract][Full Text] [Related]
8. 5-Methoxypsoralen as a specific stimulating agent of melatonin secretion in humans.
Souetre E; Salvati E; Belugou JL; Krebs B; Darcourt G
J Clin Endocrinol Metab; 1990 Sep; 71(3):670-4. PubMed ID: 2394773
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effect of 5-methoxypsoralen: a preliminary report.
Souêtre E; Salvati E; Belugou JL; Robert P; Brunet G; Darcourt G
Psychopharmacology (Berl); 1988; 95(3):430-1. PubMed ID: 3137632
[TBL] [Abstract][Full Text] [Related]
10. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
Eckerberg B; Lowden A; Nagai R; Akerstedt T
Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
[TBL] [Abstract][Full Text] [Related]
11. Low dose melatonin improves sleep in healthy middle-aged subjects.
Attenburrow ME; Cowen PJ; Sharpley AL
Psychopharmacology (Berl); 1996 Jul; 126(2):179-81. PubMed ID: 8856838
[TBL] [Abstract][Full Text] [Related]
12. Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones.
Rajaratnam SM; Dijk DJ; Middleton B; Stone BM; Arendt J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4303-9. PubMed ID: 12970302
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects.
Hajak G; Rodenbeck A; Bandelow B; Friedrichs S; Huether G; Rüther E
Eur Neuropsychopharmacol; 1996 May; 6(2):149-53. PubMed ID: 8791041
[TBL] [Abstract][Full Text] [Related]
14. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
Berg M; Ros AM
Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
[TBL] [Abstract][Full Text] [Related]
15. Psoralens in association with seasonal affective disorder.
Partonen T
Med Hypotheses; 1998 Jun; 50(6):481-2. PubMed ID: 9710320
[TBL] [Abstract][Full Text] [Related]
16. Influence of subchronic intake of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled, double-blind trial.
Nickelsen T; Demisch L; Demisch K; Radermacher B; Schöffling K
J Pineal Res; 1989; 6(4):325-34. PubMed ID: 2732892
[TBL] [Abstract][Full Text] [Related]
17. Liquid formulations of 8-methoxypsoralen (8-MOP) and 5-MOP: a prospective double-blind crossover assessment of acute non-phototoxic adverse effects.
George SA; Ferguson J
Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):33-5. PubMed ID: 1390121
[TBL] [Abstract][Full Text] [Related]
18. Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEG.
Cajochen C; Kräuchi K; von Arx MA; Möri D; Graw P; Wirz-Justice A
Neurosci Lett; 1996 Apr; 207(3):209-13. PubMed ID: 8728487
[TBL] [Abstract][Full Text] [Related]
19. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
20. Effect of pharmacological daytime doses of melatonin on human mood and performance.
Dollins AB; Lynch HJ; Wurtman RJ; Deng MH; Kischka KU; Gleason RE; Lieberman HR
Psychopharmacology (Berl); 1993; 112(4):490-6. PubMed ID: 7871062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
